D
Diane Warden
Researcher at University of Texas at Dallas
Publications - 20
Citations - 10582
Diane Warden is an academic researcher from University of Texas at Dallas. The author has contributed to research in topics: Major depressive disorder & STAR*D. The author has an hindex of 18, co-authored 20 publications receiving 9252 citations. Previous affiliations of Diane Warden include University of Pittsburgh & University of Texas Southwestern Medical Center.
Papers
More filters
Journal ArticleDOI
Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
A. John Rush,Madhukar H. Trivedi,Stephen R. Wisniewski,Andrew A. Nierenberg,Jonathan W. Stewart,Diane Warden,George Niederehe,Michael E. Thase,Philip W. Lavori,Barry D. Lebowitz,Patrick J. McGrath,Jerrold F. Rosenbaum,Harold A. Sackeim,David J. Kupfer,James F. Luther,Maurizio Fava +15 more
TL;DR: The acute and longer-term treatment outcomes associated with each of four successive steps in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial are described and compared.
Journal ArticleDOI
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice
Madhukar H. Trivedi,A. John Rush,Stephen R. Wisniewski,Andrew A. Nierenberg,Diane Warden,Louise Ritz,Grayson Norquist,Robert H Howland,Barry D. Lebowitz,Patrick J. McGrath,Kathy Shores-Wilson,Melanie M. Biggs,Goundappa K. Balasubramani,Maurizio Fava +13 more
TL;DR: The response and remission rates in this highly generalizable sample with substantial axis I and axis III comorbidity closely resemble those seen in 8-week efficacy trials.
Journal ArticleDOI
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
Maurizio Fava,A. John Rush,Jonathan E. Alpert,Goundappa K. Balasubramani,Stephen R. Wisniewski,Cheryl N. Carmin,Melanie M. Biggs,Sidney Zisook,Andrew F. Leuchter,Robert H Howland,Diane Warden,Madhukar H. Trivedi +11 more
TL;DR: Remission was significantly less likely and took longer to occur in these patients than in those with nonanxious depression, and ratings of side effect frequency, intensity, and burden, as well as the number of serious adverse events, were significantly greater in the anxious depression group.
Journal ArticleDOI
What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression
Bradley N. Gaynes,Diane Warden,Madhukar H. Trivedi,Stephen R. Wisniewski,Maurizio Fava,A. John Rush,A. John Rush +6 more
TL;DR: The authors provide an overview of the STAR*D study, a large-scale practical clinical trial to determine which of several treatments are the most effective "next-steps" for patients with major depressive disorder whose symptoms do not remit or who cannot tolerate an initial treatment and, if needed, ensuing treatments.
Journal ArticleDOI
Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.
Andrew A. Nierenberg,Mustafa M. Husain,Madhukar H. Trivedi,Maurizio Fava,Diane Warden,S. R. Wisniewski,Sachiko Miyahara,A. J. Rush +7 more
TL;DR: Patients with remission of MDD after treatment with citalopram continue to experience selected residual depressive symptoms, which increase the risk of relapse.